Atlas FDA

Radiesse® Injectable Implant

FDA premarket approval P050037/S126 · decided 2023-06-08

Approval details

PMA number
P050037
Supplement
S126
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Radiesse® Injectable Implant
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2023-05-09
Decision date
2023-06-08
Days to decision
30 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval for revisions to the clinician labeling and patient labeling as a result of postmarket surveillance data.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29